# FDA Inspection 914497 - Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. - February 06, 2015

Source: https://www.keypedia.com/records/fda_inspections/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/2907af0c-b411-48ed-9251-aa1d0041f80e
Source feed: FDA_Inspections

> FDA Inspection 914497 for Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. on February 06, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 914497
- Company Name: Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
- Inspection Date: 2015-02-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 914497 - 2015-02-06](https://www.keypedia.com/records/fda_inspections/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/b9910dda-248b-4b75-a188-d57fbf350aa4)
- [FDA Inspection 833837 - 2013-05-17](https://www.keypedia.com/records/fda_inspections/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/36ebbabe-f6d5-4348-8b91-653621fd01ca)
- [FDA Inspection 765467 - 2012-01-20](https://www.keypedia.com/records/fda_inspections/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/1a73ad03-4282-4023-aab8-00cb7d7d3c5b)

Company: https://www.keypedia.com/companies/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/99535d65-fff9-419e-bf57-d11ae158e2e4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c